Skip to main content

ModafinilChats

About James Butturn

ModafinilChats is an independent explainer project written by an independent nootropics researcher who reads the primary literature and reports what it does — and does not — support.

James Butturn

Independent nootropics researcher

Background

James trained in biomedical science and worked in pharmacology research before moving into science writing. Most of that work involved reading trial protocols closely enough to see how often a headline finding rests on a single small study, an unusual endpoint, or a population that looks nothing like the general reader.

The project began out of frustration with the two sources most people land on when they search for information about modafinil: hype-driven forum threads that treat anecdote as evidence, and manufacturer documents that disclose the minimum required and little else. Neither answers the ordinary question of what the research actually reports.

His mission here is narrow and stated plainly: translate peer-reviewed research into plain language, with full citations, and be explicit about the limits of the evidence — including where the honest answer is that the data are thin or absent.

Editorial approach

Every page is written independently and describes what studies and regulatory documents report, in which populations, and with what limitations.

Pages describe what studies and regulatory documents report, in which populations, and with what limitations. Effect sizes are reported alongside direction of effect. Where a mechanism is simplified for readability, that is stated.

Citations currently appear as bracketed placeholders such as [Source: Study Name, Year] and will be replaced with full references.

Corrections welcome

If a statement on this site is inaccurate, out of date, or missing a citation, tell us and we will review it.